Antibacterial effects of human group IIA and group XIIA phospholipase A2 against Helicobacter pylori in vitro

APMIS. 2006 Feb;114(2):127-30. doi: 10.1111/j.1600-0463.2006.apm_330.x.

Abstract

Group IIA phospholipase A2 (PLA2-IIA) is an enzyme which has important roles in inflammation and infection. Recently, a novel human secretory PLA2 called group XIIA PLA2 (PLA2-XIIA) has been identified. Both PLA2-IIA and PLA2-XIIA are bactericidal against Gram-positive bacteria like many other secretory PLA2s. However, PLA2-XIIA is the only known PLA2 displaying significant bactericidal activity against the Gram-negative bacterium Escherichia coli. We examined the antibacterial properties of recombinant human PLA2-IIA and PLA2-XIIA against Helicobacter pylori, a Gram-negative bacterium, in vitro. PLA2-IIA was not bactericidal against H. pylori, whereas PLA2-XIIA effectively killed H. pylori at a concentration of 50 microg/ml but was not bactericidal at concentrations of 0.5 microg/ml and 5 microg/ml.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Colony Count, Microbial
  • Group II Phospholipases A2
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / growth & development*
  • Humans
  • Phospholipases A / pharmacology*
  • Phospholipases A2
  • Recombinant Proteins / pharmacology
  • Stomach Diseases / drug therapy*
  • Stomach Diseases / microbiology*

Substances

  • Anti-Bacterial Agents
  • Recombinant Proteins
  • Phospholipases A
  • Group II Phospholipases A2
  • Phospholipases A2